Non-specificity of messenger RNA of α-fetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 9, 1998, Pages 885-891

  Kedda, Mary Anne ^a   Kew, Michael C ^a,c   Skelton, Michelle ^a   Hodkinson, John ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Albumin mRNA; Peripheral blood mononuclear cells; Prothrombin mRNA; Surgical resection

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; MESSENGER RNA; PROTHROMBIN;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONONUCLEAR CELL; NEGRO; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031721245     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00756.x     Document Type: Article

References (29)

1. Ringe B, Pichlmayr R, Wittekind C, Tusch MS. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation. World J. Surg. 1991; 15: 270-85.
2. Nagasue N, Uchida M, Makino Y et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-94.
3. Olthoff K, Millis JM, Rososve M, Goldstein LJ, Ramming KP, Busutil RW. Is liver transplantation justified for the treatment of hepatic malignancies? Arch. Surg. 1990; 125: 1296-8.
4. Pichlmayr R, Weimann A, Ringe B. Indication for transplantation in hepatobiliary malignancy. Hepatology 1994; 20 (Suppl.): S33-40.
5. Moss TJ, Sanders DGJ. Detection of neuroblastoma cells in blood. J.Clin.Oncol. 1990; 8: 736-40.
6. Matsumura M, Niwa Y, Kato N et al. Detection of α-feto-protein mRNA as an indicator of hematogenous spreading hepatocellular carcinoma in the circulation: A possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20: 1418-25.
7. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338: 1227-9.
8. Mattano LA, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res. 1992; 52: 4701-5.
9. Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 1994; 106: 239-42.
10. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 1995; 21: 403-7.
11. Chou H-C, Sheu J-C, Huang G-T, Wang J-T, Chen D-S. Albumin messenger RNA is not specific for circulating hepatoma cells. Gastroenterology 1994; 102: 630-1.
12. Chelly J, Concordet JP, Kaplan JC, Kahn A. Illegitimate transcription: Transcription of any gene in any cell type. Proc. Natl Acad. Sci. USA 1989; 86: 2617-21.
13. Müller C, Petermann D, Pfeffel F, Oesterreicher C, Fugger R. Lack of specificity of albumin-mRNA positive cells as a marker of circulating hepatoma cells. Hepatology 1997; 25: 896-9.
14. Komeda T, Fukuda Y, Sando T et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995; 75: 2214-19.
15. Nambu S, Nishimori H, Saeki M, Higuchi K, Watanabe A. α-Fetoprotein messenger RNA in peripheral blood as a marker of circulating hepatocellular carcinoma cells. Int. Hepatol. Commun. 1995; 5: 217-21.
16. Kew MC. Clinical, pathologic and etiologic heterogeneity in hepatocellular carcinoma: Evidence from southern Africa. Hepatology 1981; 1: 366-9.
17. Golombick T, Bezwoda WR. In vitro maintenance of a new ovarian cancer cell line in protein-free media: A potential model for autonomous growth and tumor progression. Eur. J. Cell. Biol. 1991; 56: 459-63.
18. King MA, Kew MC, Kuyl JM, Atkinson PM. A comparison between des-γ-carboxy prothrombin and α-fetoprotein as markers of hepatocellular carcinoma in southern African blacks. J. Gastroenterol. Hepatol. 1989; 4: 17-24.
19. Kwok S, Higuchi R. Avoiding false-positives with PCR. Nature 1989; 339: 237-8.
20. Levy JI, Geddes EW, Kew MC. The chest radiograph in primary liver cancer: An analysis of 449 cases. S. Afr. Med. J. 1976; 50: 1323-6.
21. Tavill AS, McCullough AJ. Protein metabolism and the liver. In: Millward-Sadler GH, Wright R, Arthur MJP, eds. Wright's Liver and Biliary Disease. Saunders: London, 1992; pp. 79-106.
22. McLeod JF, Cooke NE. The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: Detection of transcripts in multiple tissues. J. Biol. Chem. 1989; 264: 21760-9.
23. Tomiya T, Nagoshi S, Fujiwara K. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 1992; 15: 1-4.
24. Shiraishi T, Morimoto S, Koh E, Fukuo K, Ogihara T. Increased release of platelet derived growth factor from platelets in chronic liver disease. Eur. J. Clin. Chem. Clin. Biochem. 1994; 32: 5-9.
25. Jucker M, Gunther A, Gradl G et al. The met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma. Leuk. Res. 1994; 18: 7-16.
26. Berardi AC, Wang A, Abraham J, Scadden DT. Basic fibroblast growth factor mediates its effects on committed myeloid progenitors by direct action and has no effect on haemopoietic stem cells. Blood 1995; 86: 2123-9.
27. Kew MC, van Staden L, Bellingan A. Serum α-fetoprotein concentrations in urban and rural southern African blacks with hepatocellular carcinoma. Trop. Gastroenterol. 1995; 16: 11-15.
28. Gibbs PEM, Zielzinski R, Boyd C, Dugaiczyk A. Structure, polymorphism and novel repeated DNA elements revealed by a complete sequence of the human α-fetoprotein gene. Biochemistry 1987; 26: 1332-43.
29. Tagawa M, Omata M, Ohto M. Nucleotide sequence of prothrombin gene in abnormal prothrombin-producing hepatocellular carcinoma cell lines. Cancer 1992; 69: 643-7.